Clinical Trials · NCT07239570
A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- Peter Rossing
- Enrollment
- 125
- Start date
- Jun 2025
- Locations
- 4 sites, 4 countries
- Primary endpoint
- Chronic eGFR slope